Emerging Microbes & Infections SCIE

国际简称：EMERG MICROBES INFEC 参考译名：新兴微生物和感染

主要研究方向：IMMUNOLOGY-MICROBIOLOGY 非预警期刊审稿周期： 20 Weeks

《新兴微生物和感染》(Emerging Microbes & Infections)是一本由Springer Nature出版的以IMMUNOLOGY-MICROBIOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
227 年发文量
8.4 IF影响因子
开放是否OA
31 H-index
2012 创刊年份
1 issue/year 出版周期
English 出版语言

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

[ 查看全部 ]

投稿咨询加急咨询

Emerging Microbes & Infections期刊信息

ISSN：2222-1751
出版语言：English
是否OA：开放
E-ISSN：2222-1751
出版地区：ENGLAND
是否预警：否
出版商：Springer Nature
出版周期：1 issue/year
创刊时间：2012
开源占比：0.9586
Gold OA文章占比：95.91%
OA被引用占比：0.9983...
出版国人文章占比：0.33
出版撤稿占比：0
研究类文章占比：95.59%

Emerging Microbes & Infections CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

26.2

2.316

1.653

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery	Q1	3 / 157	98%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Parasitology	Q1	2 / 79	98%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Infectious Diseases	Q1	9 / 344	97%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Microbiology	Q1	6 / 182	96%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Epidemiology	Q1	6 / 148	96%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Virology	Q1	4 / 80	95%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology	Q1	13 / 236	94%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Emerging Microbes & Infections中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	INFECTIOUS DISEASES 传染病学 IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学	1区 2区 2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 INFECTIOUS DISEASES 传染病学 MICROBIOLOGY 微生物学	2区 2区 2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	INFECTIOUS DISEASES 传染病学 IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学	1区 2区 2区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 INFECTIOUS DISEASES 传染病学 MICROBIOLOGY 微生物学	2区 2区 2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	INFECTIOUS DISEASES 传染病学 IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学	1区 2区 2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学	2区 2区

Emerging Microbes & Infections JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	16 / 181	91.4%
学科：INFECTIOUS DISEASES	SCIE	Q1	8 / 132	94.3%
学科：MICROBIOLOGY	SCIE	Q1	14 / 161	91.6%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	7 / 181	96.41%
学科：INFECTIOUS DISEASES	SCIE	Q1	5 / 132	96.59%
学科：MICROBIOLOGY	SCIE	Q1	8 / 161	95.34%

Emerging Microbes & Infections历年数据统计

影响因子

中科院分区

Emerging Microbes & Infections中国学者发文选摘

1、Epidemiological characteristics and molecular features of carbapenem-resistant Enterobacter strains in China: a multicenter genomic study
Author: Zhu, Zhichen; Xie, Xiaofang; Yu, Hua; Jia, Wei; Shan, Bin; Huang, Bin; Qu, Fen; Niu, Siqiang; Lv, Jinnan; Gao, Qizhao; Qian, Feinan; Tian, Xiangxiang; Zhai, Yaxuan; Wen, Yicheng; Yang, Chengcheng; Zhu, Jie; Tang, Yiwei; Chen, Liang; Du, Hong

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2148562
2、Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
Author: Zhu, Liguo; Mao, Naiying; Yi, Changhua; Simayi, Aidibai; Feng, Jialu; Feng, Yi; He, Min; Ding, Songning; Wang, Yin; Wang, Yan; Wei, Mingwei; Hong, Jie; Li, Chuchu; Tian, Hua; Zhou, Lu; Peng, Jiefu; Zhang, Shihan; Song, Ci; Jin, Hui; Zhu, Fengcai; Xu, Wenbo; Zhao, Jun; Bao, Changjun

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2146535
3、Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020
Author: Zhou, Ziqi; Ali, Abraham; Walelign, Elias; Demissie, Getnet F.; El Masry, Ihab; Abayneh, Takele; Getachew, Belayneh; Krishnan, Pavithra; Ng, Daisy Y. M.; Gardner, Emma; Makonnen, Yilma; Miguel, Eve; Chevalier, Veronique; Chu, Daniel K.; So, Ray T. Y.; Von Dobschuetz, Sophie; Mamo, Gezahegne; Poon, Leo L. M.; Peiris, Malik

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2164218
4、Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
Author: Zhong, Guohua; Zhuang, Chunlan; Hu, Xiaowen; Chen, Qi; Bi, Zhaofeng; Jia, Xinhua; Peng, Siying; Li, Yufei; Huang, Yue; Zhang, Qiufen; Hong, Ying; Qiao, Youlin; Su, Yingying; Pan, Huirong; Wu, Ting; Wei, Lihui; Huang, Shoujie; Zhang, Jun; Xia, Ningshao

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2185456
5、Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
Author: Zheng, Xubin; Gui, Xuwei; Yao, Lan; Ma, Jun; He, Yifan; Lou, Hai; Gu, Jin; Ying, Ruoyan; Chen, Liping; Sun, Qin; Liu, Yidian; Ho, Chih-Ming; Lee, Bai-Yu; Clemens, Daniel L.; Horwitz, Marcus A.; Ding, Xianting; Hao, Xiaohui; Yang, Hua; Sha, Wei

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2187247
6、Rational development of multicomponent mRNA vaccine candidates against mpox
Author: Zhang, Rong-Rong; Wang, Zheng-Jian; Zhu, Yi-Long; Tang, Wei; Zhou, Chao; Zhao, Suo-Qun; Wu, Mei; Ming, Tao; Deng, Yong-Qiang; Chen, Qi; Jin, Ning-Yi; Ye, Qing; Li, Xiao; Qin, Cheng-Feng

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192815
7、Integrated analysis reveals important differences in the gut and oropharyngeal microbiota between children with mild and severe hand, foot, and mouth disease
Author: Zhang, Nan; Mou, Danlei; Li, Tongzeng; Chen, Zhiyun; Ma, Chunhua; Liang, Lianchun; He, Qiushui

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192819
8、Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles
Author: Zhang, Nailou; Tan, Zhongyuan; Wei, Jinbo; Zhang, Sai; Liu, Yan; Miao, Yuanjiu; Ding, Qingwen; Yi, Wenfu; Gan, Min; Li, Chunjie; Liu, Bin; Wang, Hanzhong; Zheng, Zhenhua

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2174777